IGF1 and neoplasm: Sex and tumor size did not affect IGF-1 values at baseline while IGF-1 was significantly lower in overweight or obese than in normal-weight patients (median ± IQR 164.5 ± 139.0 ng/ml versus 132.0 ± 50.0 ng/ml, p = 0.04).